Improvement in asymmetric dimethylarginine and oxidative stress in patients with limb salvage after autologous mononuclear stem cell application for critical limb ischemia

BACKGROUND: Asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthase, acts as an inhibitor of angiogenesis and is associated with an increased risk of cardiovascular mortality. Administration of stem cells may affect endogenous mechanisms that regulate ADMA production and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Stem Cell Res Ther
Main Authors: Madaric, Juraj, Valachovicova, Martina, Paulis, Ludovit, Pribojova, Jana, Mateova, Renata, Sebekova, Katarina, Postulkova, Luba, Madaricova, Terezia, Bucova, Maria, Mistrik, Martin, Vulev, Ivan
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5506609/
https://ncbi.nlm.nih.gov/pubmed/28697789
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13287-017-0622-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados